Background: Detecting and reporting drug-drug interactions (DDIs) is an important role of pharmacists. Standard operating procedures (SOPs), that can be used to manage DDIs is not a requirement at pharmacies in South Africa. SOPs create standardized methods of identifying and reporting DDIs.
Introduction
DDIs occur when two or more drugs react with each other resulting in the modification of one or more of the concurrently administered drugs, thereby decreasing their efficacy, resulting in unwanted or toxic effects, and ultimately complete treatment failure (Chatsisvili et al., 2010) . DDIs can be divided into three groups depending on the mechanism of the interaction (Admassie, Melese, Mequanent, Hailu, & Srikanth, 2013) . These include pharmacodynamic, pharmacokinetic and pharmaceutical interactions. A pharmacodynamic interaction occurs when two drugs with similar mechanisms of action are concurrently administered resulting in a synergistic or antagonistic effect. A pharmacokinetic interaction occurs when one drug alters the absorption, distribution, metabolism and excretion of another medication. Finally, a pharmaceutical interaction occurs when mixing chemically incompatible drugs outside the body resulting in the inactivation of one or both drugs (Admassie et al., 2013) . DDIs can play a significant role in the health outcomes of patients and limiting these DDIs would ultimately benefit patient therapeutic outcomes.
A medicine has many effects. Usually only one effect, being the therapeutic effect, is required for the treatment of a disease. The other effects, whether intrinsically harmful or not, may be termed 'unwanted effects'. These unwanted effects are also referred to as adverse drug reactions (ADRs). ADRs are effects that are unwanted, noxious, unpleasant or potentially harmful (Marsh, 2018) . It is the responsibility of healthcare professionals to identify and prevent ADRs which will ultimately result in an improvement in clinical effectiveness of medication. ADRs are one of the important complications of medication therapy that affects more than a million patients globally each year and can have life-threatening consequences (Makiani, Nasiripour, Hosseini, & Mahbubi, 2017) .
Pharmacists should have a sound knowledge of DDIs and ADRs to improve therapeutic outcomes, clinical effectiveness of medication and reduced hospitalisations. The World Health Organisation (WHO) advises that institutions should have proper systems in place for the early detection of DDIs and medication errors as this could potentially save lives and money (WHO, 2018a) . Systems involving the development, training and use of SOPs as a tool are an example that can assist pharmacists to carry out activities to prevent DDIs and ADRs from occurring. In South Africa, SOPs are made available by the National Department of Health and can be accessed online. Having SOPs available in pharmacies can ensure that staff are knowledgeable regarding correct procedures to follow to identify and manage DDIs. SOPs should ideally be standardised across institutions and pharmacies and should include processes and reporting systems that must be adhered to if a DDI is identified.
The standardisation of SOPs can ensure that DDIs are detected and managed the same way across all health care institutions that involve the prescribing and dispensing of medication. Furthermore, SOPs should be updated regularly in line with information such as safety alerts and warnings that are made available by relevant authorities (namely the South African Health Products Regulatory Authority, adverse event reporting units within pharmaceutical companies, and adverse events monitoring and reporting guidelines made available by the National Department of Health with regards to medicines being used and the safety thereof).
This study therefore aimed to determine the knowledge of South African pharmacists in the identification and management of DDIs in two provinces of South Africa namely Gauteng and KwaZulu-Natal (KZN), and to determine the availability and accessibility of SOPs relating to the identification and management of DDIs to practising pharmacists.
Method

Study Sample
Inclusion criteria were pharmacists working in either private or public sector pharmacies (inclusive of hospital pharmacies) from the provinces KZN and Gauteng. A database containing a list of 928 pharmacists made accessible by the South African Pharmacy Council (SAPC) was identified as the target population for the two provinces. A total of 200 respondents were selected via random sampling. 153 questionnaires were returned which yielded a response rate of 76.5%. Full ethical approval for the study was obtained from the University of KwaZulu-Natal's Biomedical Research Ethics Committee (BE523/17).
Sampling, Data Collection and Analysis
A non-probability sampling technique was used to randomly select a small sample of 200 respondents due to time limitations and onerous of sending out the samples. The software, Microsoft Random Sample Software ® , was used in the random selection of the sample ensuring that all individuals in the target population had an equal chance of being selected. The questionnaires developed for this study were sent via an online survey cloud-based software, Google forms ® , in March, 2018 to the selected sample. Feedback from 153 pharmacists was received during the period of March -May 2018 indicating a response rate of 76.5%. On receipt of the electronically completed questionnaires, the relevant data and variables such as age bracket, sex, for each answered question on the questionnaire were transferred to a password protected Microsoft Excel ® spreadsheet. No personal details of the respondents were requested.
Descriptive and inferential analyses were conducted on the results of this study. Descriptive analysis included information on frequencies, percentages, measures of central tendency (for example mean, median and mode), and measures of variability (for example range, standard deviation and variance). Inferential analysis was carried out to determine the strength of the relationships (Pearson Chi Square test) between different variables. A difference between variables with a p-value of less than 0.05 was considered to be statistically significant.
Results
Demographic Overview
One hundred and fifty-three completed questionnaires were analysed of which 66% of the respondents (n = 101) were female and 34% (n = 52) of the respondents were male. The majority of respondents were in the age group of 30-39 years (n = 63, 41.2%), followed by the age group of 20-29 (n = 29, 19%), 40-49 (n = 27, 17.6%) and >60 years (n = 24, 15.7%). The age group of 50-59 (n = 10, 6.5%) accounted for the least number of respondents. The mean age was 36 years (standard deviation was 1.3).
The majority of the respondents (58.2%) were pharmacists (n = 89), followed by 24.8% pharmacy managers (n = 38) and 17% pharmacy supervisors (n = 26). The majority of the respondents (69.3%) worked in urban areas (n = 106), with only 25.5% (n = 39) from rural areas.
Most respondents (62.7%) work in the private pharmacy sector (n = 96). Forty-six respondents (30.1%) worked in public sector pharmacies and 5.2% (n = 8) in other sectors such as academic institutions, consultancy and non-governmental organisations. Only 2% respondents work in a private-government partnership (n = 3).
The highest number of responses (53.6%) were received from pharmacists working in the Gauteng province (n = 82), followed by 41.2% from KZN (n = 63). Eight responses came from pharmacists in provinces other than Gauteng or KZN (5.2%) -these pharmacists probably moved to another province in the time lapse between the receipt of the name list and the study being conducted .It is important to note that at the time the questionnaires were sent out, they were sent out based on the information contained on the data base made available by the SAPC. This meant that although they no longer worked in KZN and Gauteng, their current registrations with the SAPC still showed that they are registered pharmacists working in either KZN or Gauteng and therefore met the inclusion criteria.
The largest number of respondents worked in public sector hospitals (n = 34, 22.2%). This was followed by pharmacists working in sectors indicated as "other" on the questionnaire (n = 32, 20.9%). Pharmacists working in private pharmacies accounted for 16.3% (n = 25), pharmacists working in private sector hospital pharmacies for 15.7% (n = 24), and pharmacists working in community pharmacies for 13.7% (n = 21). The least number of responses came from pharmacists working in community health centres (n = 17, 11.1%).
Pharmacists' Knowledge on DDIs and ADRs
Most respondents were familiar with the term pharmacovigilance (n = 143, 93.5%) and the same number of respondents were able to choose the correct definition of a DDI (n = 143, 93.5%). The number of respondents that were able to choose the correct definition of an ADR was similarly high (n = 139, 90.8%). The majority of respondents were aware that some DDIs and ADRs could be fatal (n = 148, 96.7%). The majority of respondents correctly identified contributors to DDIs (n = 98, 64.1%) and ADRs (n = 109, 71.2%).
Availability of SOPs in Pharmacies
The findings indicate that approximately the same number of pharmacists were aware of SOP's for the detection and management of DDI's and ADRs in their work place (n = 68, 44.4%) as compared to those who were not aware of any SOPs (n = 64, 41.8%). A small number of pharmacists 13.1% (n = 20), indicated that they were unsure of the existence of SOPs. More pharmacists (n = 42, 27.5%) stated that SOPs were easily accessible to all dispensing staff at their institution as compared to pharmacists who felt differently (n = 29, 19.0%). Although accessible, a concerning number of pharmacists (n = 59, 38.6%) stated that staff were not trained on the application of existing procedures.
A large number of respondents 53.6% (n = 82) were either unaware of SOPs or chose not to respond. Of the 44.7% (n = 68) pharmacists who responded that SOPs do exist in their place of employment for the detection of DDIs, more than half 51.5% (n = 35) stated that these SOPs were not regularly reviewed.
Thirty-two percent of the respondents (n = 49) stated that the availability of SOPs helped them in the management of DDIs; the rest of the respondents were not aware of SOPs or chose not to respond to the question. The majority (80.4%) of the respondents (n = 123) were of the opinion that having SOPs in place benefit the identification of DDIs in the pharmacy as well as the identification and management of ADR (85.6%; n = 131).
The availability of (P = 0.549) and access to (P = 0.746) SOPs was the same across all sectors of pharmacy.
Recommendations for the Improvement of Managing DDIs in Pharmacies
Thirty-four percent of the respondents recommended that all dispensing staff within the pharmacy should engage in training programmes in order to create an awareness with regard to the SOPs (n = 52). Increasing staff knowledge on DDIs and ADRs (40, 3%), updating SOPs (34, 22.2%) as well as increasing staff knowledge on reporting systems within existing institutional policies (40, 3%) were further recommendations for improving the management of DDIs. The use of a computer generated DDI software checker as well as the use of up to date DDI reference material (n = 34, 22%) was also recommended by the respondents.
Discussion
For over 40 years South Africa has been engaged in pharmacovigilance activities (Mehta et al., 2017) . The WHO has defined pharmacovigilance as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem (WHO, 2018b) . Pharmacists play pivotal roles in the identification, detection, prevention, and management of DDIs, drug-food interactions and ADRs (Bushra, Baloch, Jabeen, Bano, & Aslam, 2015) .
The majority of the pharmacists in this study were aware of the concept of pharmacovigilance and the fatalities involved with DDI and ADRs. It is therefore evident that the respondents in this study had an adequate knowledge regarding DDIs and ADRs and knew the importance of DDI and ADR detection and management by pharmacists. Although Pharmacists' knowledge of terminology on DDIs and ADRs was shown to be adequate, their knowledge on correct identification of contributors to DDIs and ADRs fell slightly short, leaving room for improvement and could benefit from structured training programs to guide them in carrying out their pharmacovigilance activities. A study carried out in the North West Province of South Africa found that pharmacists are familiar with the concept of pharmacovigilance, however, less than half reported their familiarity with ADRs (Joubert & Naidoo, 2016) . A study conducted in Kuwait found that more than half of the respondents were knowledgeable about the concepts of pharmacovigilance however, less than half had previously reported an ADR (Alsaleh, Alzaid, Abahussain, Bayoud, & Lemay, 2017) .
In contrast to the results found in this study and the above two studies, a study conducted in India suggested that pharmacists have inadequate knowledge of DDIs and ADRs. It was also suggested these pharmacist should undergo periodic training to aid them in carrying out pharmacovigilance activities, a recommendation that was also highlighted in this study (Rao, Radhakrishnan, & Andrade, 2011) . Similar results to the study conducted in India were found in a study conducted in Jordan whereby pharmacists in Jordan have insufficient awareness and lack of knowledge about pharmacovigilance and ADR reporting (Suyagh, Farah, & Abu Farha, 2015) .
From the above it is evident that pharmacists' knowledge differ; this problem can possibly stem from inadequate education at a tertiary level before even entering the work environment (Saverno, Malone, & Kurowsky, 2009 ) or a lack of continuing education.
Pharmacists in this study understood that SOPs can assist them in the era of large patient volumes and new medication constantly being made available on the market; SOPs can guide their practice with up to date information regarding the responsible use and management of DDIs and ADRs. SOPs in a health care setting can accelerate the initiation of therapy for individual patients by increasing the awareness of the need to vigorously and rapidly treat such patients (Kortgen, Niederprüm, & Bauer, 2006) . The Health Outcomes Research Unit and the Evaluation Unit of the KZN Department of Health has prepared guidelines which is directed at creating a standardized methodology of determining the nature, incidence and causes and reporting of adverse health events at hospitals in KZN as well as the design of SOPs for preventative actions (Mahomed, 2006) . Regular and consistent training and education programmes on SOPs for pharmacists to detect and manage DDIs will assist them to identify and manage DDIs.
Nearly equal numbers of respondents indicated the availability or unavailability of SOPs in their respective pharmacies. SOPs are "a specific set of practices that are required to be initiated and followed when specific circumstances arise" (Patel, Churi, Gurumurthy, & Madhan, 2016) . SOPs describe the procedures or a set of procedures that can be used as a response to a given event (Rao et al., 2011) . If SOPs are introduced at an institution it is important that staff are made aware of this. In a study conducted at a hospital in India, the importance of SOPs was highlighted when the quality of ADR reporting and monitoring improved after the implementation of SOPs (Patel et al., 2016) .
The majority of the respondents indicated that although the SOPs assisted them to a great extent, many were not aware or trained to use SOPs. SOPs can provide guidance not only with identifying DDIs and ADRs, but also with proper management including reporting of these. In a study conducted in Lagos, South West Nigeria, the most important reason highlighted for poor reporting of ADRs amongst community pharmacists was the fact that there was a lack of knowledge on how to report an ADR (Oreagba, Ogunleye, & Olayemi, 2011) . In this study, it was emphasised that there is an urgent need for educational programmes and training on pharmacovigilance activities and ADR reporting to increase community pharmacists' willingness to practice it.
A further study conducted in New Delhi, India, found that even though doctors had a good knowledge on ADRs, one of the major reasons highlighted for not reporting ADRs was the lack of set procedures of ADR reporting in their organization (Amrita & Singh, 2011) . A suggestion in the New Delhi study to improve ADR reporting was through implementing workshops. By increasing the awareness level of pharmacy staff on SOPs and training staff on the use of available and accessible regularly updated SOPs will ultimately aid them in the detection and management of DDIs to prevent the occurrence of ADRs.
This study was carried out in only two of the nine provinces of South Africa namely KwaZulu-Natal and Gauteng. Due to time constraints only 200 questionnaires were sent out to pharmacists of which 153 responses were received. Therefore, due to the small sample size and the geographic limitation, the results cannot be extrapolated to the entire country. The study only determined whether pharmacists were knowledgeable on the identification and management of DDIs and did not evaluate the quality of the SOPs. Furthermore, only a quantitative approach was used to gather data which did not allow for further probing of responses as is the case of a qualitative approach.
This study may assist pharmacovigilance centers to ensure that pharmacies in both healthcare sectors understand the need for creating SOPs in order to detect and manage DDIs. The findings from this study paves the way for pharmacists to revisit the use of SOPs in their work environment and to ensure that SOPs are used in a responsible manner. It is envisaged that the responsible use of SOPs would ultimately decrease the occurrence of DDIs and incidence of ADRs, thereby reducing patient health care costs, ensuring the rational use of medicines and increasing patient safety. The findings of this study will add to the body of academic knowledge and can be used to create an awareness amongst pharmacists on the importance of the availability, accessibility and regular review of SOPs in the work environment for the detection and management of DDIs and ADRs.
Recommendations for further studies are as follows: (i) to implement successful systems that are found in other countries on SOPs which will educate pharmacy staff on the detection and management of DDIs to prevent ADRs; (ii) for a holistic picture of SOPs related to DDIs and ADRs in South Africa, this study can be expanded to include all provinces of South Africa, and over a longer time period with a larger sample evaluated; (iii) studies evaluating the information contained in SOPs will be of value for quality assurance; and (iv) conducting a qualitative study approach to probe pharmacists responses would add value on the successes or failures of SOP implementation.
Conclusion
Pharmacists in South Africa, irrespective of the sector they work in, have a knowledge of DDIs and ADRs. While pharmacists understand the benefit of having SOPs in place to identify and manage DDIs and ADRs, many pharmacists were unaware of SOPs in their work environment. Therefore, it is recommended that pharmacists should be introduced to the use of SOPs in order for them to become aware of their availability and accessibility within their work environment. The SOPs should be updated regularly and pharmacists must be informed of the regular update via consistent training programmes.
Of the pharmacist who responded to being aware of SOPs in their work environment, more than half stated that the current SOPs in their work environment were not regularly reviewed. This not only highlighted the need for regular review of existing SOPs, but consistent education on SOPs. Regularly reviewed SOPs containing current National guidelines together with established staff education programmes on SOPs would ensure that every staff member are aware of current SOPs and that SOPS will be used responsibly in order to detect and manage DDIs in order to prevent ADRs.
